Supernus Pharmaceuticals
SUPN
#4336
Rank
S$2.66 B
Marketcap
$48.20
Share price
-0.83%
Change (1 day)
32.31%
Change (1 year)

P/S ratio for Supernus Pharmaceuticals (SUPN)

P/S ratio as of November 2024 (TTM): 3.14

According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.96. At the end of 2024 the company had a P/S ratio of 2.33.

P/S ratio history for Supernus Pharmaceuticals from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20242.33-10.33%
20232.60-9.95%
20222.898.04%
20212.674.64%
20202.56-19.44%
20193.17-25.35%
20184.25-37.11%
20176.7616.17%
20165.8229.35%
20154.5016.32%
20143.87-84.58%
201325.1-83.1%
2012148

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
5.95 89.58%๐Ÿ‡บ๐Ÿ‡ธ USA
17.4 455.05%๐Ÿ‡บ๐Ÿ‡ธ USA
2.49-20.68%๐Ÿ‡บ๐Ÿ‡ธ USA
4.93 57.21%๐Ÿ‡บ๐Ÿ‡ธ USA
4.27 36.01%๐Ÿ‡บ๐Ÿ‡ธ USA